Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-6 of 6
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
28-Apr-2021Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinomaJun, T; Ozbek, U; Dharmapuri, S; Hardy-Abeloos, C; Zhu, H, et al
23-Mar-2021PRIME-HCC: Phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinomaPinato, D; Cortellini, A; Sukumaran, A; Cole, T; Pai, M, et al
22-Mar-2021Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory ScoreDettorre, G; Dolly, S; Loizidou, A; Chester, J; Jackson, A, et al
1-Jun-2021The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancerDettorre, G; Patel, M; Cortellini, A; Gennari, A; Pentheroudakis, G, et al
2-Sep-2021Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspectiveSoosaipillai, G; Wu, A; Dettorre, GM; Diamantis, N; Chester, J, et al
30-Sep-2021Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.Pinato, D; Murray, S; Forner, A; Kaneko, T; Fessas, P, et al